A Phase 1/2 Study of FOG-001 in Participants with Locally Advanced or Metastatic Solid Tumors
Clinical Trial Grant
Awarded By
Parabilis Medicines, Inc.
Start Date
May 22, 2026
End Date
May 10, 2031
Awarded By
Parabilis Medicines, Inc.
Start Date
May 22, 2026
End Date
May 10, 2031